Development of Monoclonal Antibodies Targeting Canine PD-L1 and PD-1 and Their Clinical Relevance in Canine Apocrine Gland Anal Sac Adenocarcinoma
Canine apocrine gland anal sac adenocarcinoma (AGASACA) is an aggressive canine tumor originating from the anal sac glands. Surgical resection, with or without adjuvant chemotherapy, represents the standard of care for this tumor, but the outcome is generally poor, particularly for tumors diagnosed...
Main Authors: | Lucia Minoli, Luca Licenziato, Mikolaj Kocikowski, Marzia Cino, Katarzyna Dziubek, Selina Iussich, Antonella Fanelli, Emanuela Morello, Marina Martano, Ted Hupp, Borek Vojtesek, Maciej Parys, Luca Aresu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/24/6188 |
Similar Items
-
Prognostic Value of PD-L1, PD-1 and CD8A in Canine Diffuse Large B-Cell Lymphoma Detected by RNAscope
by: Luca Aresu, et al.
Published: (2021-06-01) -
A case of apocrine cystadenoma
by: Juan CHENG, et al.
Published: (2024-01-01) -
Bilateral multiple axillary apocrine hidrocystomas accompanied by apocrine hyperplasia: A rare presentation
by: Shailaja Shukla, et al.
Published: (2014-01-01) -
Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma
by: Emanuela Maria Morello, et al.
Published: (2021-06-01) -
Development and characterization of mouse anti-canine PD-L1 monoclonal antibodies and their expression in canine tumors by immunohistochemistry in vitro
by: Sirintra Sirivisoot, et al.
Published: (2023-12-01)